citalopram has been researched along with Brachial Paresis in 2 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A selective serotonergic drug (citalopram) or a placebo was administered using a mean dosage of 10 mg/day in combination with physiotherapy." | 2.74 | A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. ( Acler, M; Fiaschi, A; Manganotti, P; Robol, E, 2009) |
| "A 28-year-old woman had thunderclap headache (TCH), after 7 days she had left hemiparesis." | 1.35 | Reversible cerebral vasoconstriction syndrome: case report. ( Bek, S; Demirkaya, S; Eroğlu, E; Odabaşi, Z; Oz, O; Ulaş, UH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acler, M | 1 |
| Robol, E | 1 |
| Fiaschi, A | 1 |
| Manganotti, P | 1 |
| Oz, O | 1 |
| Demirkaya, S | 1 |
| Bek, S | 1 |
| Eroğlu, E | 1 |
| Ulaş, UH | 1 |
| Odabaşi, Z | 1 |
1 trial available for citalopram and Brachial Paresis
| Article | Year |
|---|---|
A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients.
Topics: Administration, Oral; Aged; Brain; Citalopram; Dominance, Cerebral; Double-Blind Method; Evoked Pote | 2009 |
1 other study available for citalopram and Brachial Paresis
| Article | Year |
|---|---|
Reversible cerebral vasoconstriction syndrome: case report.
Topics: Adult; Angiography, Digital Subtraction; Anti-Inflammatory Agents, Non-Steroidal; Brain Infarction; | 2009 |